Keqiang Zhang

机构：City Of Hope National Medical Center, Central South University, Hunan Cancer Hospital · ORCID：0000-0002-4210-4401

发表论文 171 篇 · 总被引 2567 次 · h-index 33

代表论文

• Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD (2024 · Cell Reports Medicine · 被引 22)
• A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis (2023 · BMC Medicine · 被引 16)
• Decision fatigue experience of front-line nurses in the context of public health emergency: an interpretative phenomenological analysis (2024 · BMC Nursing · 被引 12)
• Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells (2023 · Cell Communication and Signaling · 被引 12)
• Evaluation of the effectiveness and safety of disitamab vedotin in HER2-expressing 2L recurrent or metastatic cervical cancer (r/mCC): Interim results of RC48-C018. (2024 · Journal of Clinical Oncology · 被引 11)
• Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study (2025 · Journal of Clinical Oncology · 被引 8)